OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 146 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $23,000 | +27.8% | 53,905 | +65.4% | 0.00% | – |
Q1 2016 | $18,000 | -97.9% | 32,581 | -91.9% | 0.00% | -100.0% |
Q3 2015 | $846,000 | +80.0% | 401,124 | +322.6% | 0.01% | +71.4% |
Q2 2015 | $470,000 | -60.3% | 94,927 | -65.9% | 0.01% | -61.1% |
Q3 2014 | $1,185,000 | -33.4% | 278,120 | -3.3% | 0.02% | -33.3% |
Q2 2014 | $1,778,000 | +727.0% | 287,748 | +652.5% | 0.03% | +800.0% |
Q4 2013 | $215,000 | -18.3% | 38,237 | -10.9% | 0.00% | -40.0% |
Q3 2013 | $263,000 | -40.4% | 42,895 | -43.1% | 0.01% | -54.5% |
Q2 2013 | $441,000 | – | 75,399 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,250,000 | $7,725,000 | 6.48% |
Ghost Tree Capital, LLC | 250,000 | $1,545,000 | 1.09% |
Rock Springs Capital Management LP | 905,000 | $5,593,000 | 1.00% |
Palo Alto Investors LP | 1,931,324 | $11,936,000 | 0.89% |
PFM Health Sciences, LP | 4,604,958 | $28,459,000 | 0.57% |
NEA Management Company, LLC | 1,935,300 | $11,960,000 | 0.56% |
Rhenman & Partners Asset Management AB | 300,199 | $1,855,000 | 0.55% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 1,752,792 | $10,832,000 | 0.50% |
CQS Cayman LP | 660,040 | $4,079,000 | 0.25% |
FARALLON CAPITAL MANAGEMENT LLC | 2,684,300 | $16,589,000 | 0.24% |